Verition Fund Management LLC Gilead Sciences, Inc. Call Options Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $559,356 - $705,516	8,400 Added 18.5%	53,800 $4.51 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $1.89 Million - $2.19 Million	30,000 Added 194.81%	45,400 $3.11 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $1.1 Million - $1.34 Million	15,400 New	15,400 $1.13 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $625,170 - $714,105	10,500 New	10,500 $648,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.76 Million - $2.21 Million	30,400 Added 152.76%	50,300 $2.99 Million
Q4 2021 May 03, 2022	SELL	$64.88 - $73.64 $3.9 Million - $4.43 Million	-60,100 Reduced 75.13%	19,900 $1.45 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $5.01 Million - $6.42 Million	80,000 New	80,000 $5.98 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.